Verition Fund Management’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$818K Buy
61,265
+12,964
+27% +$187K ﹤0.01% 1471
2026
Q2
$719K Buy
+48,301
New +$520K ﹤0.01% 1546
2025
Q4
– Sell
-146,180
Closed -$2.19M – 3523
2025
Q3
$2.19M Buy
146,180
+23,724
+19% +$345K 0.01% 1896
2025
Q2
$1.73M Buy
122,456
+113,590
+1,281% +$2.02M 0.01% 2059
2025
Q1
$213K Sell
8,866
-7,913
-47% -$279K ﹤0.01% 3028
2024
Q4
$627K Buy
+16,779
New +$783K ﹤0.01% 2338
2022
Q4
– Sell
-170,500
Closed -$25.2M – 2163
2022
Q3
$25.2M Buy
+170,500
New +$1.24M 0.28% 50

Other funds holding BHVN

Verition Fund Management's BHVN Position: Q3 2026 in Review

Verition Fund Management increased its Biohaven (BHVN) stake by 27% in Q3 2026, buying an estimated $187K and bringing the position to 61,265 shares worth $818K. The position accounts for ﹤0.01% of the portfolio, ranked #1471.

Verition Fund Management first reported a position in BHVN in Q3 2022 and has held it in 7 quarters since. The position peaked at $25.2M in Q3 2022. 304 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

  • Verition Fund Management held 61,265 shares of Biohaven worth $818K as of Q3 2026.
  • Verition Fund Management bought 12,964 Biohaven shares in Q3 2026, an estimated $187K.
  • Biohaven made up ﹤0.01% of Verition Fund Management's portfolio in Q3 2026, its #1471 holding.
  • Verition Fund Management first reported a position in Biohaven in Q3 2022 and has held it in 7 quarters since.
  • Verition Fund Management's Biohaven position peaked at $25.2M in Q3 2022.
  • 304 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.